JP2022538076A5 - - Google Patents
Info
- Publication number
- JP2022538076A5 JP2022538076A5 JP2021576253A JP2021576253A JP2022538076A5 JP 2022538076 A5 JP2022538076 A5 JP 2022538076A5 JP 2021576253 A JP2021576253 A JP 2021576253A JP 2021576253 A JP2021576253 A JP 2021576253A JP 2022538076 A5 JP2022538076 A5 JP 2022538076A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- crystalline form
- diffraction peaks
- fumarate
- characteristic diffraction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910542355 | 2019-06-21 | ||
| CN201910542355.6 | 2019-06-21 | ||
| PCT/CN2020/097482 WO2020253875A1 (zh) | 2019-06-21 | 2020-06-22 | 一种化合物的盐、其晶型以及制备方法与应用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022538076A JP2022538076A (ja) | 2022-08-31 |
| JP2022538076A5 true JP2022538076A5 (cg-RX-API-DMAC7.html) | 2023-06-28 |
Family
ID=74040655
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021576253A Pending JP2022538076A (ja) | 2019-06-21 | 2020-06-22 | 化合物の塩、塩の結晶形体およびその製造方法と使用 |
Country Status (16)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116113628B (zh) * | 2020-08-31 | 2026-07-17 | 甘李药业山东有限公司 | 一种含cdk4/6抑制剂的药物组合物 |
| WO2022242563A1 (zh) * | 2021-05-17 | 2022-11-24 | 甘李药业股份有限公司 | 一种cdk4/6抑制剂的医药用途 |
| WO2024208265A1 (zh) * | 2023-04-04 | 2024-10-10 | 苏州开拓药业股份有限公司 | 具有刺猬通路拮抗剂活性手性杂环化合物的盐型及其晶型 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL150524A0 (en) * | 2000-01-07 | 2003-02-12 | Transform Pharmaceuticals Inc | High-throughput formation, identification, and analysis of diverse solid-forms |
| CN106810536A (zh) | 2015-11-30 | 2017-06-09 | 甘李药业股份有限公司 | 一种蛋白激酶抑制剂及其制备方法和医药用途 |
-
2020
- 2020-06-18 AR ARP200101717A patent/AR119184A1/es not_active Application Discontinuation
- 2020-06-22 MX MX2022000051A patent/MX2022000051A/es unknown
- 2020-06-22 WO PCT/CN2020/097482 patent/WO2020253875A1/zh not_active Ceased
- 2020-06-22 BR BR112021025944A patent/BR112021025944A2/pt unknown
- 2020-06-22 CA CA3144546A patent/CA3144546A1/en active Pending
- 2020-06-22 JP JP2021576253A patent/JP2022538076A/ja active Pending
- 2020-06-22 KR KR1020227002390A patent/KR20220041090A/ko not_active Withdrawn
- 2020-06-22 AU AU2020296048A patent/AU2020296048A1/en not_active Withdrawn
- 2020-06-22 PH PH1/2021/553151A patent/PH12021553151A1/en unknown
- 2020-06-22 CN CN202080045649.9A patent/CN115708409B/zh active Active
- 2020-06-22 US US17/596,721 patent/US20220168302A1/en not_active Abandoned
- 2020-06-22 EP EP20827805.1A patent/EP3988546A4/en not_active Withdrawn
-
2021
- 2021-12-21 CL CL2021003438A patent/CL2021003438A1/es unknown
- 2021-12-21 IL IL289231A patent/IL289231A/en unknown
-
2022
- 2022-01-20 ZA ZA2022/00964A patent/ZA202200964B/en unknown
- 2022-01-21 CO CONC2022/0000502A patent/CO2022000502A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2670416T3 (es) | Compuestos de imidazo[4,5-c]quinolin-2-ona y su uso en el tratamiento de cáncer | |
| AU2015292425B2 (en) | 2-H-indazole derivatives as cyclin-dependent kinase (CDK) inhibitors and therapeutic uses thereof | |
| JP5207386B2 (ja) | ピリミジン−２，４−ジアミンおよびその使用 | |
| CA3188077A1 (en) | Egfr inhibitor, preparation method therefor and application thereof | |
| JP4740878B2 (ja) | キナーゼインヒビターとしてのピロロトリアジン化合物 | |
| JP2022513971A (ja) | Ｋｉｆ１８ａ阻害剤として有用なヘテロアリールアミド | |
| CA3098336A1 (en) | Crystal form of c-met inhibitor and salt form thereof and preparation method therefor | |
| EP3746072B1 (en) | 2h-indazole derivatives as cdk4 and cdk6 inhibitors and therapeutic uses thereof | |
| WO2025214350A1 (en) | Macrocyclic compounds as ras inhibitors for the treatment of cancer | |
| CA2974788C (en) | A 2-pyrimidinyl substituted pyridinyl heterocyclic compound and a pharmaceutical composition comprising the same | |
| AU2016328692B2 (en) | New compounds | |
| EP3373932B1 (en) | Crystalline form of a substituted quinoline compound and pharmaceutical compositions thereof | |
| AU2019316858B2 (en) | Smad3 inhibitors | |
| CN104507944A (zh) | 作为fgfr抑制剂的蝶啶 | |
| JP2010520187A (ja) | 新規ピリミジン誘導体 | |
| JP7790746B2 (ja) | ヘテロアリール誘導体、そのヘテロアリール誘導体の調製方法、及びそのヘテロアリール誘導体を活性成分として含む医薬組成物 | |
| CN115708409A (zh) | 一种化合物的盐、其晶型以及制备方法与应用 | |
| CN108047205B (zh) | 2-(2，4，5-取代苯氨基)嘧啶衍生物、其制备方法及其在制备抗肿瘤药物中的应用 | |
| WO2022262691A1 (en) | Heterocyclic compounds as sos1 inhibitors | |
| TW200530187A (en) | 3-cyano-quinoline derivatives with antiproliferative activity | |
| US20250345339A1 (en) | Doses and regimens of her2 inhibitors | |
| CN109593102A (zh) | 一种氘代二苯氨基嘧啶类化合物的制备方法及其晶型 | |
| CN107108633A (zh) | 作为PI3Kβ抑制剂的杂环基连接的咪唑并哒嗪衍生物 | |
| AU2016328693B2 (en) | Bi-heteroaryl substituted 1,4-benzodiazepines and uses thereof for the treatment of cancer | |
| JP2025501305A (ja) | ヘテロ芳香族窒素酸化物化合物、その調製方法及びその使用 |